Pain News and Research

Latest Pain News and Research

Epidural analgesia may provide best form of pain relief for colorectal surgery patients

A new study in the March issue of Anesthesiology suggests epidural analgesia (EA) may be a more effective component in the perioperative care of patients undergoing elective open colorectal surgery than the proposed alternative, continuous wound infiltration of local anesthetics (CWI).

23 Feb 2013

EO2 Concepts develops innovative dressing for difficult-to-heal wounds

EO2 Concepts has developed an innovative dressing for difficult-to-heal wounds that is as easy to apply as a Band-Aid.

23 Feb 2013

Genentech receives FDA approval for Kadcyla to treat HER2-positive metastatic breast cancer

The U.S. Food and Drug Administration today approved Kadcyla (ado-trastuzumab emtansine), a new therapy for patients with HER2-positive, late-stage (metastatic) breast cancer.

23 Feb 2013

Florida Hospital Pepin Heart Institute, USF partner for novel gene therapy trial

Cardiovascular disease specialists at Florida Hospital Pepin Heart Institute and Dr. Kiran C. Patel Research Institute affiliated with the University of South Florida announced they have enrolled their first patients into a clinical trial testing a novel gene therapy for the treatment of heart failure after ischemic injury. The therapy may promote the regeneration of heart tissue by encouraging the body to deploy more stem cells to the injury site.

22 Feb 2013

Looming cuts fuel debate over Medicare and Medicaid spending

As the March 1 deadline for the sequester approaches, news outlets analyze the impact budget cuts might have on the U.S. economy in general and on Medicare specifically.

22 Feb 2013

Breast cancer tests: an interview with Dr Steven Quay, CEO of Atossa Genetics

Breast cancer is a major concern throughout the world. It is the number 1 cancer among women and in the Western world it generates approximately one new case per minute: 24 hours a day 7 days a week.

22 Feb 2013

FDA approves new vial size for CSL Behring’s Privigen to treat primary immunodeficiency

CSL Behring today announced that the United States Food and Drug Administration has approved a 40 g (400 mL) vial size for Privigen, immune globulin intravenous [human].

21 Feb 2013

Study looks at natural history of cervical spondylolisthesis

Follow-up data on patients with degenerative disease of the upper (cervical) spinal vertebrae show little or no evidence of worsening degeneration over time, according to a study in the February 15 issue of Spine.

21 Feb 2013

Bracelet-like device with magnetic beads can control gastroesophageal reflux disease

A bracelet-like device with magnetic beads can control the chronic digestive disorder gastroesophageal reflux disease, according to a study published online today in the New England Journal of Medicine.

21 Feb 2013

Ultrathin nanowire-based electrode helps capture signals from brain nerve cells

Electrodes operated into the brain are today used in research and to treat diseases such as Parkinson's. However, their use has been limited by their size. At Lund University in Sweden, researchers have, for the first time, succeeded in implanting an ultrathin nanowire-based electrode and capturing signals from the nerve cells in the brain of a laboratory animal.

21 Feb 2013

Viewpoints: ACOs are doomed to fail; The need to expand Medicaid in Texas; The case against malpractice changes in Iowa

Spurred by the Affordable Care Act, hundreds of pilot programs called Accountable Care Organizations have been launched over the past year, affecting tens of millions on Medicare and many who have commercial health insurance.

21 Feb 2013

Osteopontin plays a role in X-linked hypophosphatemia

Diagnosed in toddlers, X-linked hypophosphatemia (XLH) is the most common form of heritable rickets, in which soft bones bend and deform, and tooth abscesses develop because infections penetrate soft teeth that are not properly calcified. Researchers at McGill University and the Federal University of Sao Paulo have identified that osteopontin, a major bone and tooth substrate protein, plays a role in XLH. Their discovery may pave the way to effectively treating this rare disease.

21 Feb 2013

NIAID-funded Phase I trial to evaluate two related candidate vaccines against shigellosis

Researchers have launched an early-stage human clinical trial of two related candidate vaccines to prevent infection with Shigella, bacteria that are a significant cause of diarrheal illness, particularly among children.

21 Feb 2013

Immune Pharmaceuticals commences Phase II study with bertilimumab to treat ulcerative colitis

Immune Pharmaceuticals Ltd., a privately held Israeli company, and EpiCept Corporation announced today that Immune is initiating, following authorization from Israeli health authorities, a Phase II double-blind placebo controlled study with its lead drug, bertilimumab, in patients with moderate-to-severe ulcerative colitis.

21 Feb 2013

Dabigatran decreases risk of recurrent venous thromboembolism

New findings from two double-blind, randomized trials, RE-MEDY and RE-SONATE, show that dabigatran 150 mg twice daily reduces the risk of recurrent venous thromboembolism (VTE).

21 Feb 2013

UCB seeks FDA and EMA marketing authorization for Cimzia to treat active psoriatic arthritis

UCB announced today two new regulatory filings with the US Food and Drug Administration (FDA) and with the European Medicines Agency (EMA) to extend the marketing authorization for Cimzia (certolizumab pegol) for the treatment of adult patients with active psoriatic arthritis (PsA) and for adult patients with active axial spondyloarthritis (axSpA).

20 Feb 2013

Pain News and Research

Latest Pain News and Research

Epidural analgesia may provide best form of pain relief for colorectal surgery patients

EO2 Concepts develops innovative dressing for difficult-to-heal wounds

Genentech receives FDA approval for Kadcyla to treat HER2-positive metastatic breast cancer

Florida Hospital Pepin Heart Institute, USF partner for novel gene therapy trial

Looming cuts fuel debate over Medicare and Medicaid spending

Breast cancer tests: an interview with Dr Steven Quay, CEO of Atossa Genetics

FDA approves new vial size for CSL Behring’s Privigen to treat primary immunodeficiency

Study looks at natural history of cervical spondylolisthesis

Bracelet-like device with magnetic beads can control gastroesophageal reflux disease

Ultrathin nanowire-based electrode helps capture signals from brain nerve cells

Viewpoints: ACOs are doomed to fail; The need to expand Medicaid in Texas; The case against malpractice changes in Iowa

Osteopontin plays a role in X-linked hypophosphatemia

NIAID-funded Phase I trial to evaluate two related candidate vaccines against shigellosis

Immune Pharmaceuticals commences Phase II study with bertilimumab to treat ulcerative colitis

Dabigatran decreases risk of recurrent venous thromboembolism

UCB seeks FDA and EMA marketing authorization for Cimzia to treat active psoriatic arthritis

Dog owners concerned about daily living with osteoarthritis

Growth in opioid use prompts safety concerns

Symptom severity, hospice patient distress not necessarily linked

Ark., N.Y. head in opposite directions on abortion regulation

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Pain News and Research

Latest Pain News and Research

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Newsletters you may be interested in